Allergy/Asthma News

The prevalence of children who showed up to their asthma checkups increased with the use of telehealth during the COVID-19 pandemic, according to recent data.

A new study found no benefit of inhaled corticosteroid use in protecting against COVID-19-related mortality in patients with asthma and COPD.

The frequency of severe COVID-19 does not appear to differ between those with and those without atopic diseases, according to research presented at this year’s virtual American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

Researchers validated an algorithm in a new cohort of patients with suspected walnut and pecan allergy, and they said it reduced the number of oral food challenges required for diagnosis by almost 80%.

Luz Fonacier, MD, professor at NYU Long Island School of Medicine, will be installed as president of the American College of Allergy, Asthma and Immunology on Saturday, Nov. 14, during the organization’s annual scientific meeting, held virtually from Nov. 13 to 15.

An elevated risk for developing asthma among children delivered by cesarean section may be caused by differences in their gut microbiome, according to research published in Science Translational Medicine.

The FDA has released draft guidance to recommend — but not require — food manufacturers to declare sesame on products’ ingredients lists.

Use of biologic therapies in patients with severe, uncontrolled asthma treated by subspecialists in the United States is common, according to data from the real-world, observational CHRONICLE study.

Benralizumab eliminated the use of maintenance oral corticosteroids in oral corticosteroid-dependent patients with severe asthma with a broad range of blood eosinophil counts, according to high-level results of the phase 3b PONENTE trial.

Maternal psychological distress during pregnancy is associated with increased risk for asthma development and lung function decline in children, according to study findings published in Thorax.